PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer

Clinical trial NCT05187208 · UNKNOWN

Trial details

NCT number: NCT05187208
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Ovarian Cancer Ovarian Cancer Stage III Ovarian Cancer Stage IV

Start date: 2022-01-01
Primary completion: 2025-12-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.